Lindenhofgruppe Geschäftsbericht 2018

Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperations- partner / Sponsor Outcomes after different minimally-invasive glaucoma surgeries (ID: 2018-01874) Ophthalmologie Prof. Dr. med. Justus Garweg Swiss Eye Institute An open-label, randomized, active-controlled, parallel- group, Phase-3b study of the efficacy, safety, and tolerability of 2 mg aflibercept administered by intravitreal injections using two different treatment regimens to subjects with neovascular age-related macular degeneration (nAMD) (AZURE 16598) Ophthalmologie Prof. Dr. med. Justus Garweg Bayer Outcomes of third line therapy with biologicals for refractory chronic endogeneous uveitis in Switzerland (ID: 2017-01992) Ophthalmologie Prof. Dr. med. Justus Garweg Clinique de l´Oeil (GE), Universitäts- spital Zürich, Insel Gruppe, Hopital Ophtal- mique Jules- Gonin (LS), Universitätsspital Basel (BS) Eine zweijährige, randomisierte, doppelmaskierte, multi- zentrische Phase-3-Studie mit zwei Behandlungsgruppen zur Untersuchung der Wirksamkeit und Sicherheit von Brolucizumab versus Aflibercept bei erwachsenen Patienten mit diabetischem Makulaödem (KITE RTH2 258B2302) Ophthalmologie Prof. Dr. med. Justus Garweg Novartis Determination of genetic susceptibility in frequent recurrences of ocular toxoplasmosis (ID : 2017-01848) Ophthalmologie Prof. Dr. med. Justus Garweg Université de Strasbourg An open-label, randomized, active-controlled, parallel- group, Phase-3b study of the efficacy, safety, and tolerability of three different treatment regimens of 2 mg aflibercept ad- ministered by intravitreal injections to subjects with diabetic macular edema (DME) (Violet 17613/ INC number 1005566) Ophthalmologie Prof. Dr. med. Justus Garweg Bayer Conservative treatment of distal biceps tendon ruptures Orthopädie Sonnenhof Dr. med. Philipp Bissig, PD Dr. med. Richard Nyffeler – Quadrizeps tendon technique ACL perpair Orthopädie Sonnenhof Prof. Dr. med. Stefan Eggli – Individual Trochlear TKA (Patent Application Pending) Orthopädie Sonnenhof Prof. Dr. med. Stefan Eggli – Geschäftsbericht 2018 82 Lehre und Forschung